community rating (0 votes): 


Fortrea is a transformative force in clinical trial research, design, and device development. As a provider of comprehensive Phase I through IV clinical trial management, clinical pharmacology, patient access solutions, and other enabling services, Fortrea partners with emerging and large biopharma, medical device, and diagnostic companies to drive healthcare innovation worldwide. With a focus on advancing health equity, Fortrea is committed to creating diverse and inclusive clinical trials that eliminate gaps in participation. Through scientific rigor and a team of more than 19,000 professionals, Fortrea enables advances in medicine, offering tailored clinical trial solutions across therapeutic areas, including cardiovascular, dermatology, diabetes and endocrinology, hepatology, infectious disease, inflammation, nephrology, neuroscience, oncology, ophthalmology, respiratory and pulmonary, and rheumatoid arthritis. Visit our website to explore our career opportunities and get involved in clinical trials.



No Reviews Yet

Be the first to review one of our webinars!

Upcoming Webinars

Previous Webinars

Bringing Ophthalmology Trials into Focus: Reducing Patient Burden, Improving Efficiency and Incorporating Cell and Gene Therapy
Discover an informative webinar exploring patient-centered approaches shaping ophthalmology trials, uniting stakeholders for better treatments and outcomes. Clinical trials in ophthalmology require special considerations at every stage, including trial design, recruitment strategies, patient outreach and engagement, assessments and data collection and management of investigational products or devices. The key to success is putting the patients and their caregivers at the center when considering the overall approach to the trial. This panel session is fortunate to include the father of a child affected by Leber hereditary optic neuropathy (LHON) and will open with the perspective of a parent and active patient advocate. The speakers will address advances in trial design specific to rare/genetic diseases of the eye, with a focus on cell and gene therapy, the need to work collaboratively in this space to match advanced therapeutic trial design to the unique needs of investigating ocular diseases and how new perspectives on patient centricity is leading to the evolution of these trials. Join this webinar to gain insights into how sponsors, service providers, investigator sites, caregivers and patient advocacy groups can work together to accelerate the pace of bringing new treatments to these patients, for better outcomes and improved quality of life. Keywords: Clinical Trials, Rare Disease, Gene Therapy, Clinical Research, Patient-Centricity, CRO, Patient Recruitment, Cell Therapy, Eye Disease, Rare Disease Clinical Trials, Vision, Ophthalmology, Cell & Gene Therapies
1/30/2024 4:00 PM